Lineberger Comprehensive Cancer Center and Department of Microbiology & Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
J Virol. 2013 Jan;87(2):798-806. doi: 10.1128/JVI.01851-12. Epub 2012 Oct 31.
Kaposi's sarcoma-associated herpesvirus (KSHV) infection is correlated with three human malignancies and can establish lifelong latent infection in multiple cell types within its human host. In order to establish and maintain infection, KSHV utilizes multiple mechanisms to evade the host immune response. One such mechanism is the expression of a family of genes with homology to cellular interferon (IFN) regulatory factors (IRFs), known as viral IRFs (vIRFs). We demonstrate here that KSHV vIRF1, -2, and -3 have a differential ability to block type I interferon signaling mediated by Toll-like receptor 3 (TLR3), a receptor we have previously shown to be activated upon KSHV infection. vIRF1, -2, and -3 inhibited TLR3-driven activation of IFN transcription reporters. However, only vIRF1 and vIRF2 inhibited increases in both IFN-β message and protein levels following TLR3 activation. The expression of vIRF1 and vIRF2 also allowed for increased replication of a virus known to activate TLR3 signaling. Furthermore, vIRF1 and vIRF2 may block TLR3-mediated signaling via different mechanisms. Altogether, this report indicates that vIRFs are able to block IFN mediated by TLRs but that each vIRF has a unique function and mechanism for blocking antiviral IFN responses.
卡波济肉瘤相关疱疹病毒(KSHV)感染与三种人类恶性肿瘤相关,并可在其人类宿主的多种细胞类型中建立终身潜伏感染。为了建立和维持感染,KSHV 利用多种机制来逃避宿主的免疫反应。其中一种机制是表达一系列与细胞干扰素(IFN)调节因子(IRF)具有同源性的基因,称为病毒 IRF(vIRF)。我们在此证明,KSHV vIRF1、-2 和 -3 具有不同的能力来阻断 Toll 样受体 3(TLR3)介导的 I 型干扰素信号,我们之前已经证明 TLR3 在 KSHV 感染时被激活。vIRF1、-2 和 -3 抑制 TLR3 驱动的 IFN 转录报告基因的激活。然而,只有 vIRF1 和 vIRF2 抑制 TLR3 激活后 IFN-β 信使和蛋白水平的增加。vIRF1 和 vIRF2 的表达也允许激活 TLR3 信号的病毒复制增加。此外,vIRF1 和 vIRF2 可能通过不同的机制阻断 TLR3 介导的信号。总之,本报告表明 vIRF 能够阻断 TLR 介导的 IFN,但每个 vIRF 都有阻止抗病毒 IFN 反应的独特功能和机制。